Molly Mermin

Molly Mermin has worked as a Research and Development Chemist at Boulder Scientific Company since October 2022. Prior to this role, they were a Medicinal Chemistry Research Associate at Cytokinetics from September 2021 to September 2022. From December 2018 to September 2021, they worked as a Content Editor at LibreTexts. Molly also gained experience as an Undergraduate Research Assistant at the University of California, Davis from September 2019 to February 2020, where they assisted on a project focused on finding a genetic therapy for Angelman Syndrome.

Molly Mermin attended the University of California, Davis from 2017 to 2021, where they pursued a Bachelor of Science (BS) degree in Pharmaceutical Chemistry.